Results of surgical treatment of inferior vena cava tumor thrombi in renal cell carcinoma
Authors:
P. Berek 1; I. Kopolovets 1; V. Sihotský 1; M. Virág 1; C. Dzsinich 2; M. Frankovičová 1
Authors‘ workplace:
Klinika cievnej chirurgie VÚSCH a. s. a Lekárska fakulta Univerzita P. J. Šafárika, Košice
1; Oddelenie kardiovaskulárnej a hrudnej chirurgie, Ústredná vojenská nemocnica – Štátne zdravotné centrum, Budapešt
2
Published in:
Rozhl. Chir., 2020, roč. 99, č. 4, s. 167-171.
Category:
Original articles
doi:
https://doi.org/10.33699/PIS.2020.99.4.167–171
Overview
Introduction: Thrombosis of inferior vena cava (IVC) is an important complication amongst oncological patients. Tumor thrombus of IVC is characteristic for patients with renal cell carcinoma, occurring in 10−18%. The aim of the work is to analyze of surgical treatment in patients with cancer thrombosis of inferior vena cava in kidney cancer.
Methods: Between 2010 and 2019 we treated 32 patients with kidney cancer complicated by thrombotic infiltration of the inferior vena cava. According to Nesbitt classification the levels of thrombotic infiltration of the inferior vena cava were: I–8 (25%), II–14 (43.8%), III–6 (18.8%), and IV–4 (12.5%). Nephrectomy with thrombectomy of the cancer thrombus in the inferior vena cava was performed in all patients. In addition to laparotomy, sternotomy was approached in 4 patients with Nesbitt IV and in 2 patients with Nesbitt III.
Results: Primary suture of IVC was performed in 26 patients; angioplasty of IVC was performed in 4 patients; and resection of IVC with replacement using a polytetrafluoroethylene interposition graft was done in 2 patients. Radical surgical treatment was performed in 27 (84.3%) patients, and palliative in 5 (15.6%) patients. In the postoperative period, 1 (3.1%) patient (Nesbitt IV) died of cardiac failure during hospitalisation. Two-year survival was observed in 75% of the cases.
Conclusion: Tumorous infiltration of IVC is associated with a high potential for tumour embolisation to the lungs, leading to the formation of multiple metastases and spreading of the underlying disease. Postoperative comfort is improved considerably after nephrectomy of the affected kidney and removal of the tumour thrombus, including IVC resection as appropriate, and when combined with oncological treatment, the survival rate is increased significantly, as well.
Keywords:
inferior vena cava − renal cell carcinoma − tumour thrombus
Sources
1. Novotny R, Chlupac J, Marada T, et al. Transabdominal two-cavity approach for radical nephrectomy combined with inferior vena cava thrombectomy for malignant thrombus caused by renal cell carcinoma: a case series. J Med Case Rep. 2018;12(1):313. doi: 10.1186/s13256-018-1845-2.
2. Baláž V. Správa hlavného odborníka MZSR pre urológiu o operačnej činnosti lôžkových oddelení za rok 2018. Klin urol. 2019;15(3):145−149.
3. Breza J. Chirurgická liečba nádorov obličiek. Onkológia 2010;5(5):266−269.
4. Lachvac L, Svajdler M, Valansky L, et al. Juxtaglomerular cell tumor, causing fetal demise. Int Urol Nephrol. 2011;43(2):365−70. doi: 10.1007/s11255-010-9782-z.
5. Ge L, Tian X, Ma J, et al. Surgical treatment for Xp11.2 translocation renal cell carcinoma with venous thrombus: A STROBE-compliant study. Medicine (Baltimore). 2019;98(37):e17172. doi: 10.1097/MD.0000000000017172.
6. Rusin VI, Korsak VV, Rusin AV, et al. Radical nephrectomy and thrombectomy in patients, suffering renocellular cancer, complicated by tumoral thrombosis of renal vein and vena cava inferior. Klin Khir.2013;1: 21–26.
7. Topaktaş R, Ürkmez A, Tokuç E, et al. Surgical management of renal cell carcinoma with associated tumor thrombus extending into the inferior vena cava: A 10-year single-center experience. Turk J Urol. 2019;45(5):345−350. doi: 10.5152/tud.2019.95826.
8. Ciancio G, Gonzalez J, Shirodkar SP, et al. Transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. EurUrol. 2011;59(3):401−406. doi.org/10.1016/j.eururo.2010.07.028.
9. Serena G, Gonzalez J, Gaynor JJ, et al. Pulmonary tumor embolization as early manifestation in patients with renal cell carcinoma and tumor thrombus: Perioperative management and outcomes. J Card Surg. 2019;34(10):1018−1024.doi.org/10.1111/jocs.14182.
10. Nesbitt JC, Soltero ER, Dinney CPN. Surgical management of renall cell carcinoma with inferior vena cava tumor trombus. Ann Thorac Surg. 1997;63:1592–1600.
11. Rusin VI, Korsak VV, Boiko SO, et al. Surgical treatment of renal cell carcinoma with internally venous dissemination and implantation of thrombus intra vena cava inferior tissue. Hospital Surgery Journal named by L. Ya Kovalchuk 2015;2:5–8.
12. Janek J, Kminiak R, Necpal R, et al. Chirurgická liečba nádorov dolnej dutej žily. Vask med. 2016;8(1):28–30.
13. Rutherford’s Vascular Surgery. 8th ed. Venous tumours 2014:989–1002.
14. Morris PD, Furtado R, Pulitano C, et al. Inferior vena cava resection and reconstruction with bovine pericardium for renal cell carcinoma: complications and outcomes.Urology 2019;134:143−147. doi: 10.1016/j.urology.2019.09.006.
15. Liu Z, Tang S, Tian X, et al. Foley catheter-assisted six-step thrombectomy technique in the surgical management of renal cell carcinoma with Mayo level II to IV tumor thrombus. J Int Med Res. 2019;47(5):2104−2115. doi: 10.1177/0300060519836912.
16. Mastoraki A, Mastoraki S, Tsikala-Vafea M, et al. Prognostic benefit of surgical management of renal cell carcinoma invading the inferior vena cava. Indian J Surg Oncol. 2017;8(1):14–18. doi: 10.1007/s13193-016-0528-y.
17. Syčová-Milá Z. Súčasný pohľad na liečbu karcinómu obličky. Onkológia 2010;5(5):262–265.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2020 Issue 4
Most read in this issue
- The effects and use of negative pressure wound therapy – a set of case reports
- Pseudomyxoma peritonei (PMP) and its therapy – 20 years’ experience of a single surgical department
- Current possibilities of minimally invasive therapy of oesophageal diverticula.
- Surgical treatment of breast carcinoma after neoadjuvant therapy